JP2024535134A5 - - Google Patents
Info
- Publication number
- JP2024535134A5 JP2024535134A5 JP2024542230A JP2024542230A JP2024535134A5 JP 2024535134 A5 JP2024535134 A5 JP 2024535134A5 JP 2024542230 A JP2024542230 A JP 2024542230A JP 2024542230 A JP2024542230 A JP 2024542230A JP 2024535134 A5 JP2024535134 A5 JP 2024535134A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163249110P | 2021-09-28 | 2021-09-28 | |
| CN202111140592 | 2021-09-28 | ||
| US63/249,110 | 2021-09-28 | ||
| CN202111140592.3 | 2021-09-28 | ||
| PCT/CN2022/121554 WO2023051490A1 (zh) | 2021-09-28 | 2022-09-27 | Glp-1受体激动剂固体组合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024535134A JP2024535134A (ja) | 2024-09-26 |
| JP2024535134A5 true JP2024535134A5 (https=) | 2025-10-06 |
| JPWO2023051490A5 JPWO2023051490A5 (https=) | 2025-10-06 |
Family
ID=85780433
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024542230A Pending JP2024535134A (ja) | 2021-09-28 | 2022-09-27 | Ｇｌｐ－１受容体アゴニストの固形組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250332157A1 (https=) |
| EP (1) | EP4410793A4 (https=) |
| JP (1) | JP2024535134A (https=) |
| CA (1) | CA3233453A1 (https=) |
| WO (1) | WO2023051490A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202521533A (zh) | 2023-09-14 | 2025-06-01 | 香港商歌禮製藥(中國)有限公司 | Glp-1r 激動劑及其治療方法 |
| US12291530B1 (en) | 2023-11-24 | 2025-05-06 | Ascletis Pharma (China) Co., Limited | GLP-1R agonist and therapeutic method thereof |
| WO2025158275A1 (en) | 2024-01-24 | 2025-07-31 | Pfizer Inc. | Combination therapy using glucose-dependent insulinotropic polypeptide receptor antagonist compounds and glp-1 receptor agonist compounds |
| WO2025189141A1 (en) | 2024-03-08 | 2025-09-12 | Annapurna Bio, Inc. | Methods for treating obesity and increasing weight loss |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5755217B2 (ja) | 2009-03-30 | 2015-07-29 | トランステック・ファーマ，エルエルシー | 置換アゾアントラセン誘導体、その医薬組成物とその使用の方法 |
-
2022
- 2022-09-27 US US18/691,835 patent/US20250332157A1/en active Pending
- 2022-09-27 EP EP22874875.2A patent/EP4410793A4/en active Pending
- 2022-09-27 WO PCT/CN2022/121554 patent/WO2023051490A1/zh not_active Ceased
- 2022-09-27 JP JP2024542230A patent/JP2024535134A/ja active Pending
- 2022-09-27 CA CA3233453A patent/CA3233453A1/en active Pending